Clinical Trial Update: A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated escalating doses of romidepsin in combination with CHOP for Peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Istodax (romidepsin)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Peripheral T Cell Lymphoma | Phase 1, Phase 2 | Status: COMPLETED